217 related articles for article (PubMed ID: 23214327)
1. Analysis of sentinel nodes biopsy in breast cancer--12 years after introduction into clinical practice.
Golubović A; Ranisavljević M; Radovanović Z; Selaković V; Mandić A; Dilas D
Med Pregl; 2012; 65(9-10):363-7. PubMed ID: 23214327
[TBL] [Abstract][Full Text] [Related]
2. The clinical role of micrometastatic disease in sentinel lymph nodes in breast cancer.
Golubovic A; Ranisavljevic M; Djilas D; Stoiljkovic B; Selakovic V; Radovanovic Z; Bogdanovic D; Plzak A
J BUON; 2012; 17(1):46-50. PubMed ID: 22517692
[TBL] [Abstract][Full Text] [Related]
3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
6. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
7. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in elderly breast cancer patients.
Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
Schrenk P; Shamiyeh A; Wayand W
Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
[TBL] [Abstract][Full Text] [Related]
10. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy in patients with breast cancer and previous breast surgery].
Blanco I; Díaz D; Moriyón C; Santamaría L; Díez MA; López MT; Padín H; Cantero F; Artime S; Domínguez F; Aira FJ; Alvarez-Obregón R
Rev Esp Med Nucl; 2011; 30(4):223-8. PubMed ID: 21530010
[TBL] [Abstract][Full Text] [Related]
13. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
Cocilovo C; Boolbol SK; Valdes E; Feldman S
Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
[TBL] [Abstract][Full Text] [Related]
14. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
[TBL] [Abstract][Full Text] [Related]
16. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
17. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
18. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
20. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]